Trillium Therapeutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trillium Therapeutics

TRIL 20.78

+0.2%

Nov 3 2:45 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (207)	10/1/2018 9:10:38 PM
From: tuck	Read Replies (2) of 294

Competitors coming out of the woodwork. Have we mentioned ALX Oncology's version here yet? ALX148 Haven't had a position in a while. Apparently, TRIL can dose a bit higher than they thought, but they sure lost some time getting to that point, and now their leadership and safety advantage seems to have evaporated. Might sell puts if it nears $5, though, as it's till in the race and undervalued relative to others in the space. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next